Insmed Incorporated (INSM)

Insmed Incorporated experienced significant selling activity over the past ninety days, with insiders offloading approximately 35.7 million dollars in equity. These transactions occurred amid a 15.1 percent stock decline and a recent earnings report showing a 35.3 percent miss. Executives and directors accounted for the entirety of these divestments, reflecting a notable lack of buying.
Ticker: INSM Exchange: NSM


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Insmed Incorporated. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.8
Sara Bonstein Former Officer Officer
Transaction date
Proposed sale
Price
207.79
Quantity 54,009
Value US$4,892,803
2.4
Brennan David R Non-Executive Director
Transaction date
Sale
Price
175.34
Quantity 71,482 -13.8%
Value US$433,450
2.4
Brennan David R Director Non-Executive Director
Transaction date
Proposed sale
Price
220.00
Quantity 86,595
Value US$1,077,148
2.4
Brennan David R Director Non-Executive Director
Transaction date
Proposed sale
Price
123.99
Quantity 25,000
Value US$3,099,729
3.6
SHAROKY MELVIN MD Non-Executive Director
Transaction date
Sale
Price
127.53
Quantity 5,000 -100.0%
Value US$637,650
3.6
MELVIN SHAROKY Director Non-Executive Director
Transaction date
Proposed sale
Price
127.53
Quantity 5,000
Value US$637,637
2.9
Adsett Roger Chief Operating Officer Officer
Transaction date
Sale
Price
133.27
Quantity 239,850 -70.8%
Value US$31,964,810
2.9
Roger Adsett Officer Officer
Transaction date
Proposed sale
Price
133.26
Quantity 239,850
Value US$31,963,198
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Planned sale
Price
129.40
Quantity 18,278 -23.2%
Value US$2,365,173
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Planned sale
Price
127.00
Quantity 8,895 -10.1%
Value US$1,129,665
2.7
Martina Flammer Officer Officer
Transaction date
Proposed sale
Price
128.61
Quantity 27,173
Value US$3,494,755
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
106.43
Quantity 5,872 -2.2%
Value US$624,957
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
105.62
Quantity 4,828 -1.8%
Value US$509,933
3.3
William Lewis Officer Officer
Transaction date
Proposed sale
Price
106.06
Quantity 10,700
Value US$1,134,867
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
118.52
Quantity 3,359 -1.3%
Value US$398,109
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
117.62
Quantity 2,335 -0.9%
Value US$274,643
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
116.55
Quantity 5,005 -1.9%
Value US$583,333
3.3
William Lewis Officer Officer
Transaction date
Proposed sale
Price
117.40
Quantity 10,699
Value US$1,256,029
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Planned sale
Price
110.60
Quantity 7,448 -11.0%
Value US$823,749
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Planned sale
Price
109.02
Quantity 4,854 -6.7%
Value US$529,183
2.7
Martina Flammer Officer Officer
Transaction date
Proposed sale
Price
109.97
Quantity 12,302
Value US$1,352,864
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
106.27
Quantity 1,292 -0.5%
Value US$137,301
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
105.27
Quantity 2,456 -0.9%
Value US$258,543
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
104.28
Quantity 3,723 -1.4%
Value US$388,234
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
103.10
Quantity 1,836 -0.7%
Value US$189,292
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
102.34
Quantity 12,091 -4.3%
Value US$1,237,393
3.3
William Lewis Officer Officer
Transaction date
Proposed sale
Price
103.31
Quantity 21,398
Value US$2,210,653
3.2
Smith Michael Alexander Chief Legal Officer Officer
Transaction date
Planned sale
Price
95.82
Quantity 1,806 -4.6%
Value US$173,051
3.2
Michael Smith Officer Officer
Transaction date
Proposed sale
Price
95.81
Quantity 1,806
Value US$173,039
3.2
Michael Smith Officer Officer
Transaction date
Proposed sale
Price
95.81
Quantity 1,806
Value US$173,039
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
94.03
Quantity 6,515 -2.5%
Value US$612,605
3.3
William Lewis Officer Officer
Transaction date
Proposed sale
Price
94.03
Quantity 6,515
Value US$612,576
2.7
Martina Flammer Officer Officer
Transaction date
Proposed sale
Price
103.77
Quantity 1,858
Value US$192,811
2.7
Martina Flammer Officer Officer
Transaction date
Proposed sale
Price
103.77
Quantity 1,858
Value US$192,811
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Planned sale
Price
103.78
Quantity 1,858 -3.0%
Value US$192,823
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Planned sale
Price
103.78
Quantity 1,858 -3.0%
Value US$192,823
2.8
Bonstein Sara Chief Financial Officer Officer
Transaction date
Sale
Price
102.27
Quantity 2,404 -3.4%
Value US$245,857
2.8
Bonstein Sara Chief Financial Officer Officer
Transaction date
Sale
Price
102.27
Quantity 2,404 -3.4%
Value US$245,857
2.9
Adsett Roger Chief Operating Officer Officer
Transaction date
Sale
Price
102.27
Quantity 2,370 -2.3%
Value US$242,380
2.9
Adsett Roger Chief Operating Officer Officer
Transaction date
Sale
Price
102.27
Quantity 2,370 -2.3%
Value US$242,380
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Sale
Price
102.27
Quantity 2,566 -4.0%
Value US$262,425
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Sale
Price
102.27
Quantity 2,566 -4.0%
Value US$262,425
3.2
Smith Michael Alexander Chief Legal Officer Officer
Transaction date
Sale
Price
102.27
Quantity 2,159 -5.2%
Value US$220,801
3.2
Smith Michael Alexander Chief Legal Officer Officer
Transaction date
Sale
Price
102.27
Quantity 2,159 -5.2%
Value US$220,801
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Sale
Price
102.27
Quantity 7,605 -2.8%
Value US$777,763
2.8
Sara Bonstein Officer Officer
Transaction date
Proposed sale
Price
102.27
Quantity 2,404
Value US$245,857
2.7
Martina Flammer Officer Officer
Transaction date
Proposed sale
Price
102.27
Quantity 2,566
Value US$262,424
2.9
Roger Adsett Officer Officer
Transaction date
Proposed sale
Price
102.27
Quantity 2,370
Value US$242,379
3.2
Michael Smith Officer Officer
Transaction date
Proposed sale
Price
102.27
Quantity 2,159
Value US$220,800
3.3
William Lewis Officer Officer
Transaction date
Proposed sale
Price
102.27
Quantity 7,605
Value US$777,763
3.2
Michael Smith Officer Officer
Transaction date
Proposed sale
Price
108.46
Quantity 6,149
Value US$666,951
3.2
Smith Michael Alexander Chief Legal Officer Officer
Transaction date
Planned sale
Price
108.47
Quantity 6,149 -12.9%
Value US$666,982
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
106.97
Quantity 7,975 -2.8%
Value US$853,086
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
106.39
Quantity 11,836 -4.0%
Value US$1,259,232
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
105.32
Quantity 5,753 -1.9%
Value US$605,906
3.3
William Lewis Officer Officer
Transaction date
Proposed sale
Price
106.33
Quantity 25,564
Value US$2,718,106
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Planned sale
Price
117.54
Quantity 10,479 -13.9%
Value US$1,231,702
2.7
Martina Flammer Officer Officer
Transaction date
Proposed sale
Price
117.53
Quantity 10,479
Value US$1,231,599
3.2
Smith Michael Alexander Chief Legal Officer Officer
Transaction date
Sale
Price
116.18
Quantity 4,109 -7.9%
Value US$477,384
2.8
Bonstein Sara Chief Financial Officer Officer
Transaction date
Sale
Price
116.18
Quantity 8,272 -10.4%
Value US$961,041
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Sale
Price
116.18
Quantity 13,283 -4.4%
Value US$1,543,219
2.9
Adsett Roger Chief Operating Officer Officer
Transaction date
Sale
Price
116.18
Quantity 5,837 -5.5%
Value US$678,143
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Sale
Price
116.18
Quantity 3,384 -4.3%
Value US$393,153
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Sale
Price
112.76
Quantity 4,470 -5.4%
Value US$504,037
2.9
Roger Adsett Officer Officer
Transaction date
Proposed sale
Price
116.18
Quantity 5,837
Value US$678,142
3.2
Michael Smith Officer Officer
Transaction date
Proposed sale
Price
116.18
Quantity 4,109
Value US$477,383
2.7
Martina Flammer Officer Officer
Transaction date
Proposed sale
Price
114.23
Quantity 7,854
Value US$897,145
2.8
Sara Bonstein Officer Officer
Transaction date
Proposed sale
Price
116.18
Quantity 8,272
Value US$961,040
3.3
William Lewis Officer Officer
Transaction date
Proposed sale
Price
116.18
Quantity 13,283
Value US$1,543,218
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Planned sale
Price
101.18
Quantity 830 -1.0%
Value US$83,979
2.7
Flammer Martina M.D. Chief Medical Officer Officer
Transaction date
Planned sale
Price
100.35
Quantity 12,119 -12.6%
Value US$1,216,142
2.7
Martina Flammer Officer Officer
Transaction date
Proposed sale
Price
100.40
Quantity 12,949
Value US$1,300,105
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
139.60
Quantity 381 -0.1%
Value US$53,188
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
139.09
Quantity 1,247 -0.4%
Value US$173,445
3.3
Lewis William Chair and CEO Executive Director
Transaction date
Planned sale
Price
137.86
Quantity 2,721 -0.9%
Value US$375,117
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-03 2026-11-03 PrS Proposed sale

Former Officer

Officer
54,009
207.79
US$4,892,803
54,009 207.79 US$4,892,803
2026-09-11 2026-09-09 S Sale Non-Executive Director
71,482 -13.8%
175.34
US$433,450
71,482 -13.8% 175.34 US$433,450
2026-09-10 2026-09-09 PrS Proposed sale

Director

Non-Executive Director
86,595
220.00
US$1,077,148
86,595 220.00 US$1,077,148
2026-09-10 2026-09-09 PrS Proposed sale

Director

Non-Executive Director
25,000
123.99
US$3,099,729
25,000 123.99 US$3,099,729
2026-08-19 2026-08-17 S Sale Non-Executive Director
5,000 -100.0%
127.53
US$637,650
5,000 -100.0% 127.53 US$637,650
2026-08-17 2026-08-17 PrS Proposed sale

Director

Non-Executive Director
5,000
127.53
US$637,637
5,000 127.53 US$637,637
2026-08-12 2026-08-10 S Sale

Chief Operating Officer

Officer
239,850 -70.8%
133.27
US$31,964,810
239,850 -70.8% 133.27 US$31,964,810
2026-08-10 2026-08-10 PrS Proposed sale

Officer

Officer
239,850
133.26
US$31,963,198
239,850 133.26 US$31,963,198
2026-08-07 2026-08-06 PlS Planned sale

Chief Medical Officer

Officer
18,278 -23.2%
129.40
US$2,365,173
18,278 -23.2% 129.40 US$2,365,173
2026-08-07 2026-08-06 PlS Planned sale

Chief Medical Officer

Officer
8,895 -10.1%
127.00
US$1,129,665
8,895 -10.1% 127.00 US$1,129,665
2026-08-06 2026-08-06 PrS Proposed sale

Officer

Officer
27,173
128.61
US$3,494,755
27,173 128.61 US$3,494,755
2026-07-24 2026-07-23 PlS Planned sale

Chair and CEO

Executive Director
5,872 -2.2%
106.43
US$624,957
5,872 -2.2% 106.43 US$624,957
2026-07-24 2026-07-23 PlS Planned sale

Chair and CEO

Executive Director
4,828 -1.8%
105.62
US$509,933
4,828 -1.8% 105.62 US$509,933
2026-07-23 2026-07-23 PrS Proposed sale

Officer

Officer
10,700
106.06
US$1,134,867
10,700 106.06 US$1,134,867
2026-07-10 2026-07-09 PlS Planned sale

Chair and CEO

Executive Director
3,359 -1.3%
118.52
US$398,109
3,359 -1.3% 118.52 US$398,109
2026-07-10 2026-07-09 PlS Planned sale

Chair and CEO

Executive Director
2,335 -0.9%
117.62
US$274,643
2,335 -0.9% 117.62 US$274,643
2026-07-10 2026-07-09 PlS Planned sale

Chair and CEO

Executive Director
5,005 -1.9%
116.55
US$583,333
5,005 -1.9% 116.55 US$583,333
2026-07-09 2026-07-09 PrS Proposed sale

Officer

Officer
10,699
117.40
US$1,256,029
10,699 117.40 US$1,256,029
2026-07-08 2026-07-06 PlS Planned sale

Chief Medical Officer

Officer
7,448 -11.0%
110.60
US$823,749
7,448 -11.0% 110.60 US$823,749
2026-07-08 2026-07-06 PlS Planned sale

Chief Medical Officer

Officer
4,854 -6.7%
109.02
US$529,183
4,854 -6.7% 109.02 US$529,183
2026-07-06 2026-07-06 PrS Proposed sale

Officer

Officer
12,302
109.97
US$1,352,864
12,302 109.97 US$1,352,864
2026-06-26 2026-06-25 PlS Planned sale

Chair and CEO

Executive Director
1,292 -0.5%
106.27
US$137,301
1,292 -0.5% 106.27 US$137,301
2026-06-26 2026-06-25 PlS Planned sale

Chair and CEO

Executive Director
2,456 -0.9%
105.27
US$258,543
2,456 -0.9% 105.27 US$258,543
2026-06-26 2026-06-25 PlS Planned sale

Chair and CEO

Executive Director
3,723 -1.4%
104.28
US$388,234
3,723 -1.4% 104.28 US$388,234
2026-06-26 2026-06-25 PlS Planned sale

Chair and CEO

Executive Director
1,836 -0.7%
103.10
US$189,292
1,836 -0.7% 103.10 US$189,292
2026-06-26 2026-06-25 PlS Planned sale

Chair and CEO

Executive Director
12,091 -4.3%
102.34
US$1,237,393
12,091 -4.3% 102.34 US$1,237,393
2026-06-25 2026-06-25 PrS Proposed sale

Officer

Officer
21,398
103.31
US$2,210,653
21,398 103.31 US$2,210,653
2026-06-24 2026-06-22 PlS Planned sale

Chief Legal Officer

Officer
1,806 -4.6%
95.82
US$173,051
1,806 -4.6% 95.82 US$173,051
2026-06-22 2026-06-22 PrS Proposed sale

Officer

Officer
1,806
95.81
US$173,039
1,806 95.81 US$173,039
2026-06-22 2026-06-22 PrS Proposed sale

Officer

Officer
1,806
95.81
US$173,039
1,806 95.81 US$173,039
2026-06-10 2026-06-08 PlS Planned sale

Chair and CEO

Executive Director
6,515 -2.5%
94.03
US$612,605
6,515 -2.5% 94.03 US$612,605
2026-06-08 2026-06-08 PrS Proposed sale

Officer

Officer
6,515
94.03
US$612,576
6,515 94.03 US$612,576
2026-06-05 2026-06-05 PrS Proposed sale

Officer

Officer
1,858
103.77
US$192,811
1,858 103.77 US$192,811
2026-06-05 2026-06-05 PrS Proposed sale

Officer

Officer
1,858
103.77
US$192,811
1,858 103.77 US$192,811
2026-06-05 2026-06-05 PlS Planned sale

Chief Medical Officer

Officer
1,858 -3.0%
103.78
US$192,823
1,858 -3.0% 103.78 US$192,823
2026-06-05 2026-06-05 PlS Planned sale

Chief Medical Officer

Officer
1,858 -3.0%
103.78
US$192,823
1,858 -3.0% 103.78 US$192,823
2026-06-05 2026-06-03 S Sale

Chief Financial Officer

Officer
2,404 -3.4%
102.27
US$245,857
2,404 -3.4% 102.27 US$245,857
2026-06-05 2026-06-03 S Sale

Chief Financial Officer

Officer
2,404 -3.4%
102.27
US$245,857
2,404 -3.4% 102.27 US$245,857
2026-06-05 2026-06-03 S Sale

Chief Operating Officer

Officer
2,370 -2.3%
102.27
US$242,380
2,370 -2.3% 102.27 US$242,380
2026-06-05 2026-06-03 S Sale

Chief Operating Officer

Officer
2,370 -2.3%
102.27
US$242,380
2,370 -2.3% 102.27 US$242,380
2026-06-05 2026-06-03 S Sale

Chief Medical Officer

Officer
2,566 -4.0%
102.27
US$262,425
2,566 -4.0% 102.27 US$262,425
2026-06-05 2026-06-03 S Sale

Chief Medical Officer

Officer
2,566 -4.0%
102.27
US$262,425
2,566 -4.0% 102.27 US$262,425
2026-06-05 2026-06-03 S Sale

Chief Legal Officer

Officer
2,159 -5.2%
102.27
US$220,801
2,159 -5.2% 102.27 US$220,801
2026-06-05 2026-06-03 S Sale

Chief Legal Officer

Officer
2,159 -5.2%
102.27
US$220,801
2,159 -5.2% 102.27 US$220,801
2026-06-05 2026-06-03 S Sale

Chair and CEO

Executive Director
7,605 -2.8%
102.27
US$777,763
7,605 -2.8% 102.27 US$777,763
2026-06-03 2026-06-03 PrS Proposed sale

Officer

Officer
2,404
102.27
US$245,857
2,404 102.27 US$245,857
2026-06-03 2026-06-03 PrS Proposed sale

Officer

Officer
2,566
102.27
US$262,424
2,566 102.27 US$262,424
2026-06-03 2026-06-03 PrS Proposed sale

Officer

Officer
2,370
102.27
US$242,379
2,370 102.27 US$242,379
2026-06-03 2026-06-03 PrS Proposed sale

Officer

Officer
2,159
102.27
US$220,800
2,159 102.27 US$220,800
2026-06-03 2026-06-03 PrS Proposed sale

Officer

Officer
7,605
102.27
US$777,763
7,605 102.27 US$777,763
2026-05-22 2026-05-22 PrS Proposed sale

Officer

Officer
6,149
108.46
US$666,951
6,149 108.46 US$666,951
2026-05-22 2026-05-22 PlS Planned sale

Chief Legal Officer

Officer
6,149 -12.9%
108.47
US$666,982
6,149 -12.9% 108.47 US$666,982
2026-05-20 2026-05-18 PlS Planned sale

Chair and CEO

Executive Director
7,975 -2.8%
106.97
US$853,086
7,975 -2.8% 106.97 US$853,086
2026-05-20 2026-05-18 PlS Planned sale

Chair and CEO

Executive Director
11,836 -4.0%
106.39
US$1,259,232
11,836 -4.0% 106.39 US$1,259,232
2026-05-20 2026-05-18 PlS Planned sale

Chair and CEO

Executive Director
5,753 -1.9%
105.32
US$605,906
5,753 -1.9% 105.32 US$605,906
2026-05-18 2026-05-18 PrS Proposed sale

Officer

Officer
25,564
106.33
US$2,718,106
25,564 106.33 US$2,718,106
2026-05-15 2026-05-14 PlS Planned sale

Chief Medical Officer

Officer
10,479 -13.9%
117.54
US$1,231,702
10,479 -13.9% 117.54 US$1,231,702
2026-05-14 2026-05-14 PrS Proposed sale

Officer

Officer
10,479
117.53
US$1,231,599
10,479 117.53 US$1,231,599
2026-05-15 2026-05-13 S Sale

Chief Legal Officer

Officer
4,109 -7.9%
116.18
US$477,384
4,109 -7.9% 116.18 US$477,384
2026-05-15 2026-05-13 S Sale

Chief Financial Officer

Officer
8,272 -10.4%
116.18
US$961,041
8,272 -10.4% 116.18 US$961,041
2026-05-15 2026-05-13 S Sale

Chair and CEO

Executive Director
13,283 -4.4%
116.18
US$1,543,219
13,283 -4.4% 116.18 US$1,543,219
2026-05-15 2026-05-13 S Sale

Chief Operating Officer

Officer
5,837 -5.5%
116.18
US$678,143
5,837 -5.5% 116.18 US$678,143
2026-05-15 2026-05-13 S Sale

Chief Medical Officer

Officer
3,384 -4.3%
116.18
US$393,153
3,384 -4.3% 116.18 US$393,153
2026-05-15 2026-05-13 S Sale

Chief Medical Officer

Officer
4,470 -5.4%
112.76
US$504,037
4,470 -5.4% 112.76 US$504,037
2026-05-13 2026-05-13 PrS Proposed sale

Officer

Officer
5,837
116.18
US$678,142
5,837 116.18 US$678,142
2026-05-13 2026-05-13 PrS Proposed sale

Officer

Officer
4,109
116.18
US$477,383
4,109 116.18 US$477,383
2026-05-13 2026-05-13 PrS Proposed sale

Officer

Officer
7,854
114.23
US$897,145
7,854 114.23 US$897,145
2026-05-13 2026-05-13 PrS Proposed sale

Officer

Officer
8,272
116.18
US$961,040
8,272 116.18 US$961,040
2026-05-13 2026-05-13 PrS Proposed sale

Officer

Officer
13,283
116.18
US$1,543,218
13,283 116.18 US$1,543,218
2026-05-13 2026-05-11 PlS Planned sale

Chief Medical Officer

Officer
830 -1.0%
101.18
US$83,979
830 -1.0% 101.18 US$83,979
2026-05-13 2026-05-11 PlS Planned sale

Chief Medical Officer

Officer
12,119 -12.6%
100.35
US$1,216,142
12,119 -12.6% 100.35 US$1,216,142
2026-05-11 2026-05-11 PrS Proposed sale

Officer

Officer
12,949
100.40
US$1,300,105
12,949 100.40 US$1,300,105
2026-05-06 2026-05-04 PlS Planned sale

Chair and CEO

Executive Director
381 -0.1%
139.60
US$53,188
381 -0.1% 139.60 US$53,188
2026-05-06 2026-05-04 PlS Planned sale

Chair and CEO

Executive Director
1,247 -0.4%
139.09
US$173,445
1,247 -0.4% 139.09 US$173,445
2026-05-06 2026-05-04 PlS Planned sale

Chair and CEO

Executive Director
2,721 -0.9%
137.86
US$375,117
2,721 -0.9% 137.86 US$375,117

See older Insmed Incorporated insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Insmed Incorporated history with Plus

Billed monthly · Cancel anytime